Retatrutide RT30 30mg*10vials

What is Retatrutide?

Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM). Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor .Retatrutide can be used for the research of obesity. Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides.

Funtion

1. 1.Preclinical research indicates Retatrutide exerts regulatory effects on mental and emotional activities, showing potential value for related physiological and pharmacological research. 2.Retatrutide possesses neuroprotective properties, which can be applied in the research and mechanism exploration of neurodegenerative conditions like Alzheimer’s and Parkinson’s disease. 3.Relevant animal studies demonstrate that Retatrutide helps optimize learning and memory performance, presenting research prospects for cognitive function regulation.
2. 4.Preclinical studies have verified that Retatrutide has analgesic bioactivity, offering research reference for the study of chronic discomfort regulation.
3. 5.Animal experiments confirm that Retatrutide can accelerate tissue repair progress, with promising research potential as an active substance for wound recovery research.
4. Application
5. 1.Retatrutide is widely applied in pharmaceutical research and related biochemical studies.
6. 2.Retatrutide belongs to a class of bioactive peptide compounds.
7. 3.Retatrutide acetate can inhibit GCGR, GIPR and GLP-1R.
8. 4.Retatrutide acetate acts on glucagon receptors to regulate physiological metabolism and energy expenditure.
9.